A/Prof Yet Hong Khor is an emerging research leader, who is in the top 0.1% of interstitial lung disease (ILD) and 0.45% of oxygen therapy researchers globally (Expertscape). In addition to dual clinical training in respiratory and sleep medicine, she completed a NHMRC-funded PhD in ILD and oxygen therapy at the University of Melbourne in 2019, and a post-doctoral fellowship at the University of British Columbia funded by an Australian Endeavour Leadership Award. Currently, she is an NHMRC Emerging Leadership fellow who leads investigator-initiated ILD research programs, as well as the Lead for Austin Health Oxygen Service and a specialist at the Austin and Alfred Health ILD Services.

Dr Yet Hong Khor is a graduate of the University of Tasmania, who attained her Fellowship to the Royal Australasian College of Physicians in 2014. After completing her NHRMC-funded PhD at the University of Melbourne in 2019, she undertook a fellowship at the Centre for Heart Lung Innovation (University of British Columbia, Canada), supported by an Australian Endeavour Scholarship. Currently, she is a post-doctoral fellow at the Institute for Breathing and Sleep, the lead for Austin Health Oxygen Service, and a physician at the Austin and Alfred Health Interstitial Lung Disease Services. Her main research interests include risk prediction and disease burden management in interstitial lung disease. She is the co-Chair of the Clinical Care and Resources Subcommittee and the Deputy Convener of the Orphan Lung Diseases, Lung Transplant, Interstitial lung Disease and Pulmonary Vascular Disease (OLIV) Special Interest Group for the Thoracic Society of Australia and New Zealand.